ArticleCureus2026
Novel Strategies to Reduce Patient No-Show Rates: Single Institutional Study at Jane H. Booker Family Health Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Patient no-shows pose a significant healthcare burden, disrupting operational efficiency, reducing access to care, and contributing to poor patient outcomes. The downstream effects of patient no-shows create substantial challenges for healthcare systems, often resulting in wasted resources, decreased productivity, and lost revenue. At the Jane H. Booker Family Health Center in Neptune, New Jersey, patient no-show rates had been steadily rising, prompting the implementation of several targeted interventions. Methods Coordinated interventions were implemented, including expanded laboratory hours, a centralized contact center, on-site social work and financial assistance programs, and a structured approach to maintaining consistency across patient-provider relationships. Interventions were introduced in a staggered manner between September 2022 and January 2023 to allow for operational feasibility and progressive implementation. A retrospective analysis of appointment data was conducted, comparing no-show rates before and after implementation of the interventions. These interventions were applied across all specialty and subspecialty services at the center, including Internal Medicine, Pediatrics, Obstetrics, Gynecology, Psychiatry, Endocrinology, Neurology, Pulmonary, Cardiology, Surgery, Nephrology, Urology, Podiatry, Rheumatology, Ophthalmology, and Gastroenterology. Results Implementation of these interventions was associated with a measurable improvement in no-show rates. The average no-show rate was 18.6% in 2022, and in 2023, following the interventions, the rate declined to 12.3%, representing an overall 33.8% relative reduction in patient no-show rate (p < 0.001). Conclusion A comprehensive, multifaceted intervention strategy was associated with a significant reduction in patient no-show rates. The strategies implemented may serve as a model for other healthcare institutions facing similar challenges. While individual strategies to reduce no-shows have been studied, few examine the combined effect of multiple interventions, highlighting the potential benefits of an integrated approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.